Author:
Lahu Gezim,Nassr Nassr,Herzog Rolf,Elmlinger Martin,Ruth Peter,Hinder Markus,Huennemeyer Andreas
Subject
Pharmacology (medical),Pharmacology
Reference27 articles.
1. Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma;Field;Exp Opin Invest Drugs,2008
2. Effect of single and repeated doses of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide;Lahu;J Clin Pharmacol,2008
3. Roflumilast: an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial;Rabe;Lancet,2005
4. Roflumilast, a novel, oral, selective PDE4 inhibitor, shows high oral bioavailability;David;J Allergy Clin Immunol,2004
5. Pharmacokinetics and safety of roflumilast, a once daily, oral, selective PDE4 inhibitor, and its active metabolite roflumilast N-oxide in healthy subjects;Huennemeyer;J Allergy Clin Immunol,2004
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献